SCHEMBL7992192

SCHEMBL7992192

Cc1cc(C)cc(C(=O)Nc2ncn(Cc3ccccc3)c2C(N)=O)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B13 Q7Z5P4 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
TSHR P16473 1/20 0.44
P2RY14 Q15391 1/20 0.43
NR1I2 O75469 2/20 0.42
POLB P06746 3/20 0.42
KDM4E B2RXH2 1/20 0.42
BRD4 O60885 1/20 0.42
OPRK1 P41145 2/20 0.41
OPRD1 P41143 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985033 0.91 NLRP3 (0.46) MEN1KMT2APOLBKDM4EOPRK1
SCHEMBL7975241 0.88 GAA (0.50) HSD17B13GAAPKMTSHRPOLB
SCHEMBL7974265 0.86 MCHR1 (0.47) HSD17B13MEN1KMT2AGAAPOLB
SCHEMBL7988029 0.84 IDO1 (0.47) HSD17B13GAAPKMTSHRPOLB
SCHEMBL7985682 0.84 GAA (0.46) HSD17B13MEN1KMT2AGAAPKM
SCHEMBL7974318 0.84 HSD17B13 (0.43) HSD17B13GAAPKMTSHRP2RY14
SCHEMBL7984492 0.83 ADORA2A (0.53) KDM4ECDK2YTHDC1
SCHEMBL7985255 0.83 ALDH1A1 (0.51) MEN1KMT2AGAAPKMTSHR
SCHEMBL7973996 0.83 POLB (0.49) MEN1KMT2APOLBKDM4EMAPT
SCHEMBL7974040 0.83 KDM4E (0.51) HSD17B13GAAPKMTSHRP2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed